Trial intelligence / Profile preview

Dexmedetomidine and postoperative pain after open liver cancer resection

ChiCTR-IPR-17011001Phase 4Recruiting

Sponsor
Beijing YouAn Hospital
Start
May 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of dexmedetomidine in postoperative pain (2 arms), sponsored by Beijing YouAn Hospital. Primary endpoints: Postoperative pain scores and Postoperative oxycodone consumption. Started May 2016; status: recruiting.

02

Drugs

dexmedetomidine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on ChiCTR-IPR-17011001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-IPR-17011001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call